R
Regina Roller-Wirnsberger
Researcher at University of Graz
Publications - 21
Citations - 597
Regina Roller-Wirnsberger is an academic researcher from University of Graz. The author has contributed to research in topics: Health care & Allergen immunotherapy. The author has an hindex of 9, co-authored 21 publications receiving 365 citations. Previous affiliations of Regina Roller-Wirnsberger include University of Crete.
Papers
More filters
Journal ArticleDOI
Frailty and multimorbidity: a systematic review and meta-analysis
Davide L. Vetrano,Davide L. Vetrano,Katie Palmer,Alessandra Marengoni,Emanuele Marzetti,Fabrizia Lattanzio,Regina Roller-Wirnsberger,Luz M. López Samaniego,Leocadio Rodríguez-Mañas,Roberto Bernabei,Graziano Onder +10 more
TL;DR: The three longitudinal studies suggest a bidirectional association between multimorbidity and frailty, which is not conclusive regarding the causal association between the two conditions.
Journal ArticleDOI
Prevalence and associations of potentially inappropriate prescriptions in Austrian nursing home residents: secondary analysis of a cross-sectional study.
Eva Mann,Burkhard Haastert,Birgit Böhmdorfer,Birgit Böhmdorfer,Thomas Frühwald,Bernhard Iglseder,Regina Roller-Wirnsberger,Gabriele Meyer +7 more
TL;DR: Cluster-adjusted multiple regression analysis showed an inverse association of PIP with cognitive impairment and significant positive associations with permanent restlessness and permanent negative attitude in residents in Austria.
Journal ArticleDOI
Key Messages for a Frailty Prevention and Management Policy in Europe from the Advantage Joint Action Consortium
L. Rodriguez Manas,I. García-Sánchez,Anne Hendry,Roberto Bernabei,Regina Roller-Wirnsberger,Branko Gabrovec,Aaron Liew,Ana Maria Carriazo,Josep Redon,Lucia Galluzzo,Jose Viña,Eleftheria Antoniadou,Tomasz Targowski,L. di Furia,Fabrizia Lattanzio,Elena Bozdog,M. Telo +16 more
TL;DR: The aim of this paper is to describe ADVANTAGE JA general structure, approach and recommendations towards a European health and social policy which will support frailty prevention in the participating MS.
Journal ArticleDOI
Transforming the future of ageing
Jean-Pierre Michel,Diana Kuh,Rose Anne Kenny,Richard B. Reilly,Liat Ayalon,Axel H. Boersch-Supan,Jacques Bringer,Alfonso José Cruz Jentoft,Giovanni Gambassi,Alan J. Gow,Tomasz Grodzicki,Lenka Lhotska,Ekaterina L. Markova,Rytis Maskeliunas,Carlo Patrono,Lene Juel Rasmussen,Regina Roller-Wirnsberger,Archana Singh-Manoux,P. Eline Slagboom,Anne Pieter van der Mei,Leo van Wissen,Jose Viña +21 more
Journal ArticleDOI
Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic
Ludger Klimek,O. Pfaar,Margitta Worm,Thomas Eiwegger,J. Hagemann,Markus Ollert,Eva Untersmayr,Karin Hoffmann-Sommergruber,A. Vultaggio,Ioana Agache,Sevim Bavbek,Apostolos Bossios,Ingrid Casper,Susan Chan,Alexia Chatzipetrou,Christian Vogelberg,Davide Firinu,P. Kauppi,A. Kolios,Akash Kothari,Andrea Matucci,Oscar Palomares,Zsolt Szépfalusi,Wolfgang Pohl,Wolfram Hötzenecker,Alexander R. Rosenkranz,Karl-Christian Bergmann,Thomas Bieber,Roland Buhl,Jeroen Buters,Ulf Darsow,Thomas Keil,Jörg Kleine-Tebbe,Susanne Lau,Marcus Maurer,Hans F. Merk,Ralph Mösges,Joachim Saloga,Petra Staubach,Uta Jappe,Klaus Rabe,Uta Rabe,Claus Vogelmeier,Tilo Biedermann,Kirsten Jung,Wolfgang Schlenter,Johannes Ring,A. Chaker,Wofgang Wehrmann,Sven Becker,Laura Freudelsperger,Norbert Mülleneisen,Katja Nemat,Wolfgang Czech,Holger Wrede,Randolf Brehler,Thomas Fuchs,P. V. Tomazic,Werner Aberer,Antje-Henriette Fink-Wagner,F. Horak,Stefan Wöhrl,Verena Niederberger-Leppin,Isabella Pali-Schöll,Regina Roller-Wirnsberger,Otto Spranger,Rudolf Valenta,Mübecell Akdis,P. M. Matricardi,François Spertini,Nicolai Khaltaev,Jean-Pierre Michel,L. Nicod,Peter Schmid-Grendelmeier,Marco Idzko,Eckard Hamelmann,Thilo Jakob,Thomas Werfel,Martin Wagenmann,Christian Taube,Erika Jensen-Jarolim,Stephanie Korn,F. Hentges,Jürgen Schwarze,Liam O´mahony,Edward F. Knol,Stefano Del Giacco,Tomás Chivato Pérez,Jean Bousquet,Anna Bedbrook,Torsten Zuberbier,Cezmi A. Akdis,Mared Jutel +92 more
TL;DR: The use of biologicals for the treatment of bronchial asthma, atopic dermatitis, chronic rhinosinusitis with nasal polyps, and spontaneous urticaria should be continued as usual in patients without suspected infection or proven SARS-CoV-2 infection.